1. Home
  2. NRP vs ABCL Comparison

NRP vs ABCL Comparison

Compare NRP & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Resource Partners LP Limited Partnership

NRP

Natural Resource Partners LP Limited Partnership

HOLD

Current Price

$97.60

Market Cap

1.3B

Sector

Energy

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.34

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRP
ABCL
Founded
2002
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.6B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
NRP
ABCL
Price
$97.60
$5.34
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$8.40
AVG Volume (30 Days)
36.0K
6.8M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
2.56%
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
$216,119,000.00
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$21.85
P/E Ratio
$11.28
N/A
Revenue Growth
54.66
160.56
52 Week Low
$95.51
$2.75
52 Week High
$128.60
$8.44

Technical Indicators

Market Signals
Indicator
NRP
ABCL
Relative Strength Index (RSI) 41.89 38.49
Support Level $97.39 $5.23
Resistance Level $101.78 $5.63
Average True Range (ATR) 2.26 0.54
MACD 0.20 -0.25
Stochastic Oscillator 33.96 0.32

Price Performance

Historical Comparison
NRP
ABCL

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. The majority of the revenue is generated from the Mineral Rights segment. Geographically, the company's business activity of the group functions through the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: